136 related articles for article (PubMed ID: 17881008)
1. Bv8/Prokineticin proteins and their receptors.
Negri L; Lattanzi R; Giannini E; Melchiorri P
Life Sci; 2007 Sep; 81(14):1103-16. PubMed ID: 17881008
[TBL] [Abstract][Full Text] [Related]
2. The prokineticins: a novel pair of regulatory peptides.
Zhou QY
Mol Interv; 2006 Dec; 6(6):330-8. PubMed ID: 17200460
[TBL] [Abstract][Full Text] [Related]
3. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells.
LeCouter J; Lin R; Tejada M; Frantz G; Peale F; Hillan KJ; Ferrara N
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2685-90. PubMed ID: 12604792
[TBL] [Abstract][Full Text] [Related]
4. Evidence that prokineticin receptor 2 exists as a dimer in vivo.
Marsango S; Bonaccorsi di Patti MC; Barra D; Miele R
Cell Mol Life Sci; 2011 Sep; 68(17):2919-29. PubMed ID: 21161321
[TBL] [Abstract][Full Text] [Related]
5. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
[TBL] [Abstract][Full Text] [Related]
6. Signaling role of prokineticin 2 on the estrous cycle of female mice.
Xiao L; Zhang C; Li X; Gong S; Hu R; Balasubramanian R; Crowley W WF; Hastings MH; Zhou QY
PLoS One; 2014; 9(3):e90860. PubMed ID: 24633064
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.
Vincenzi M; Kremić A; Jouve A; Lattanzi R; Miele R; Benharouga M; Alfaidy N; Migrenne-Li S; Kanthasamy AG; Porcionatto M; Ferrara N; Tetko IV; Désaubry L; Nebigil CG
Pharmacol Rev; 2023 Nov; 75(6):1167-1199. PubMed ID: 37684054
[TBL] [Abstract][Full Text] [Related]
8. An ancient cytokine, astakine, mediates circadian regulation of invertebrate hematopoiesis.
Watthanasurorot A; Söderhäll K; Jiravanichpaisal P; Söderhäll I
Cell Mol Life Sci; 2011 Jan; 68(2):315-23. PubMed ID: 20652616
[TBL] [Abstract][Full Text] [Related]
9. Prokineticin signaling in heart-brain developmental axis: Therapeutic options for heart and brain injuries.
Désaubry L; Kanthasamy AG; Nebigil CG
Pharmacol Res; 2020 Oct; 160():105190. PubMed ID: 32937177
[TBL] [Abstract][Full Text] [Related]
10. Bv8-prokineticins and their receptors: modulators of pain.
Negri L; Lattanzi R
Curr Pharm Biotechnol; 2011 Oct; 12(10):1720-7. PubMed ID: 21466441
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Prokineticin System to Control Chronic Pain and Inflammation.
Negri L; Maftei D
Curr Med Chem; 2018; 25(32):3883-3894. PubMed ID: 28707588
[TBL] [Abstract][Full Text] [Related]
12. HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain.
Manengu C; Zhu CH; Zhang GD; Tian MM; Lan XB; Tao LJ; Ma L; Liu Y; Yu JQ; Liu N
Inflammopharmacology; 2024 May; ():. PubMed ID: 38761314
[TBL] [Abstract][Full Text] [Related]
13. Prokineticin 2 is a catabolic regulator of osteoarthritic cartilage destruction in mouse.
Yang J; Shin Y; Kim HJ; Kim HE; Chun JS
Arthritis Res Ther; 2023 Dec; 25(1):236. PubMed ID: 38057865
[TBL] [Abstract][Full Text] [Related]
14. Effects of Prokineticins on Cerebral Cell Function and Blood-Brain Barrier Permeability.
Younes H; Kyritsi I; Mahrougui Z; Benharouga M; Alfaidy N; Marquette C
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895111
[TBL] [Abstract][Full Text] [Related]
15. Editorial: Neuropeptide GPCRs in neuroendocrinology, Volume II.
Vaudry H; Schoofs L; Civelli O; Kojima M
Front Endocrinol (Lausanne); 2023; 14():1219530. PubMed ID: 37415662
[No Abstract] [Full Text] [Related]
16. Prokineticin 2/PROK2 and Male Infertility.
Petrella C; Spaziani M; D'Orazi V; Tarani L; Terracina S; Tarani F; Micangeli G; Barbato C; Minni A; Greco A; Isidori AM; Ferraguti G; Fiore M
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289651
[TBL] [Abstract][Full Text] [Related]
17. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of chemical and natural compounds against vincristine-induced peripheral neuropathy (VIPN).
Khodaei M; Mehri S; Pour SR; Mahdavi S; Yarmohammadi F; Hayes AW; Karimi G
Naunyn Schmiedebergs Arch Pharmacol; 2022 Aug; 395(8):907-919. PubMed ID: 35562512
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of prokineticin 2 and its receptor in endometrium of recurrent implantation failure patients decreased the expression of MMP9 important for decidualization.
Zhai J; Ma L; Chang Z; Yu T
Reprod Biol Endocrinol; 2022 May; 20(1):76. PubMed ID: 35501804
[TBL] [Abstract][Full Text] [Related]
20. Prokineticin-Receptor Network: Mechanisms of Regulation.
Lattanzi R; Miele R
Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
